NCT03228264 is a NA clinical trial of teleSLT in Aphasia, sponsored by University of Bern.

Who is sponsoring NCT03228264?

NCT03228264 is sponsored by University of Bern.

What drugs are being tested in NCT03228264?

Interventions in NCT03228264: teleSLT, teleCT.

What condition does NCT03228264 study?

NCT03228264 studies Aphasia, Chronic Stroke, Post Stroke Seizure.

Is NCT03228264 still recruiting?

NCT03228264 is currently completed. Last updated 10 November 2022.

Last reviewed 2022-11-10 · How we verify

NCT03228264

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia.

Completed NA Last updated 10 November 2022

What this trial tests

NA trial testing teleSLT in Aphasia in 21 participants. Completed in 1 November 2021.

Timeline

25 September 2018

Primary endpoint
1 November 2021

1 November 2021

Quick facts

Lead sponsor	University of Bern
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	21
Start date	25 September 2018
Primary completion	1 November 2021
Estimated completion	1 November 2021
Sites	2 locations across Switzerland

Drugs / interventions tested

teleSLT
teleCT

Conditions studied

Aphasia — all drugs for Aphasia →
Chronic Stroke — all drugs for Chronic Stroke →
Post Stroke Seizure — all drugs for Post Stroke Seizure →

Sponsor

University of Bern

Who can join

18 and older, any sex, with Aphasia or Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effects of high-frequency short duration tablet-based speech and language therapy (teleSLT) mixed with cognitive training (teleCT) in chronic stroke patients. Recent studies suggest that chronic stroke patients benefit from SLT with high frequency and that cognitive abilities can play a role in sentence comprehension and production by individuals with aphasia. To investigate the effects of the distribution of training time for teleSLT and teleCT the investigators use two combinations. In the experimental group 80% of the training time will be devoted to teleSLT and 20% to teleCT whereas in the control group 20% of the training time will be devoted to teleSLT and 80% to teleCT. Both groups receive the same total amount and frequency of intervention but with different distributions. At three time points (pre-, post-test and 8 week follow-up) the patients' word finding ability is measured.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Telerehabilitation services for stroke.
Laver KE, Adey-Wakeling Z, Crotty M, Lannin NA, et al · · 2020 · cited 316× · PMID 32002991 · DOI 10.1002/14651858.cd010255.pub3
Investigating a new tablet-based telerehabilitation app in patients with aphasia: a randomised, controlled, evaluator-blinded, multicentre trial protocol.
Uslu AS, Gerber SM, Schmidt N, Röthlisberger C, et al · · 2020 · cited 2× · PMID 33177134 · DOI 10.1136/bmjopen-2020-037702

Verify or expand the search:

Other recruiting trials for Aphasia

Currently open trials in the same condition.

NCT07460037 — Chinese-Specific Speech Imagery Coding Using High-Density ECoG · NA · recruiting
NCT07397923 — Exploratory Evaluation of the Digital Therapeutic Device Zenicom for Subacute Stroke Aphasia · Phase 2 · recruiting
NCT07281313 — Aphasia Physical EXercise Study: Randomized Trial · NA · recruiting
NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia · NA · recruiting
NCT06974279 — Post-Stroke Aphasia TMS · NA · recruiting

Other University of Bern trials

Trials by the same sponsor.

NCT05940662 — Cost Effectiveness of Various Implant Placement Protocols in the Esthetic Zone · Phase 4 · suspended
NCT02919163 — Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 6 of 7) · NA · not yet recruiting
NCT02919189 — Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 5 of 7) · NA · not yet recruiting
NCT04817592 — Characterization of the Corneal Biomechanics of Patients Treated by Corneal Lenticule Extraction for Advanced Refractive · not yet recruiting
NCT06806150 — The INSPIRE Study: INvestigation of Swiss Physicians Inner-life, Resilience, and Emotions · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03228264 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bern
Last refreshed: 10 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03228264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing